Truist Securities Downgrades Amrize to Hold, Lowers Price Target to $48

Benzinga Newsdesk www.benzinga.com Negative 90.7%

Neg 90.7% Neu 0% Pos 0%

Truist Securities analyst Keith Hughes downgrades Amrize (NYSE:AMRZ) from Buy to Hold and lowers the price target from $65 to $48.